title: Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus.
abstract: The prevalence rate and disease manifestations of systemic lupus erythematosus (SLE) have been noted to vary among different ethnic groups. There has been no description in the English literature of SLE in the Vietnamese population. This is the first report, which details the clinical and laboratory features as well as an estimation of the prevalence of SLE in patients with a Vietnamese ancestry living in the United States. We performed a retrospective chart review of clinical and laboratory features of patients of Vietnamese descent with SLE. The case finding was performed by a review of the rheumatology clinic records at two large teaching hospitals in Santa Clara County searching for patients with SLE with a Vietnamese surname. In addition, we recruited patients by contacting all of the rheumatologists practicing in the county. Twenty-three patients of Vietnamese descent were identified with SLE in Santa Clara County. The estimated prevalence of SLE in the patients of Vietnamese descent was 42 cases per 100 000 persons. Eighty-seven per cent of the cases were born in Vietnam. The clinical and laboratory features of SLE were similar to prior published reviews except for a relatively high prevalence of anti-RNP antibody (54%). The patients with anti-RNP antibody exhibited features of overlap syndrome. There was a high rate of exposure to tuberculosis (TB). Fifty-eight per cent of patients had a positive purified protein derivative (PPD) skin test and 27% of patients had a history of clinical TB. Forty-four per cent of patients had evidence of hepatitis B exposure. The prevalence of SLE in the Vietnamese population in Santa Clara County is similar to that of other Asian populations. There was a relatively high prevalence of anti-RNP antibody in our patient group which was associated with overlap features. As expected in an immigrant population from Southeast Asia, there was a high rate of prior exposure to tuberculosis and hepatitis B. Clinicians should diligently screen for these infections and appropriately prophylaxe and treat patients.
authors.affiliation: Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Phan
authors.forename: T M
authors.initials: TM
authors.lastname: Bush
authors.forename: F
authors.initials: F
authors.lastname: Donald
authors.forename: M
authors.initials: M
authors.lastname: Ward
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D044466:Asian People; D001324:Autoantigens / Q000276:immunology; D002140:California / Q000453:epidemiology; D003165:Complement System Proteins / Q000378:metabolism; D004247:DNA / Q000276:immunology; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000208:ethnology* / Q000276:immunology / Q000821:virology; D008297:Male; D012189:Retrospective Studies; D017411:Ribonucleoproteins, Small Nuclear; D016036:Seroepidemiologic Studies; D014373:Tuberculin; D014744:Vietnam / Q000208:ethnology; D055517:snRNP Core Proteins
chemical_list: D000974:Antibodies, Antinuclear; D000914:Antibodies, Viral; D001324:Autoantigens; D006514:Hepatitis B Surface Antigens; D017411:Ribonucleoproteins, Small Nuclear; D014373:Tuberculin; D055517:snRNP Core Proteins; D003165:Complement System Proteins; D004247:DNA